These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8523392)

  • 1. Ethnic origin and hypertension-associated alterations in sodium-lithium countertransport kinetics.
    Hardman TC; Croft P; Barlow R; Wierzbicki AS; Feher MD; Lant AF
    J Hum Hypertens; 1995 Aug; 9(8):687-9. PubMed ID: 8523392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic characteristics of the erythrocyte sodium-lithium countertransporter in black normotensive subjects compared with three other ethnic groups.
    Hardman TC; Croft P; Morrish Z; Anto-Awoakye K; Lant AF
    J Hum Hypertens; 1998 Jan; 12(1):29-34. PubMed ID: 9482130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic behavior of the erythrocyte sodium-lithium countertransporter in nonnephropathic diabetic twins.
    Hardman TC; Dubrey SW; Leslie RD; Lant AF
    Metabolism; 1996 Oct; 45(10):1203-7. PubMed ID: 8843173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium-lithium countertransport activity in normotensive offspring of hypertensive black Africans.
    Obasohan AO; Osuji CO; Oforofuo IA
    J Hum Hypertens; 1998 Jun; 12(6):373-7. PubMed ID: 9705038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium-lithium countertransport in erythrocytes of children and adolescents with hypertension.
    Norling LL; Goldring D; Hernandez A; Robson AM; Landt M
    Dev Pharmacol Ther; 1986; 9(4):231-40. PubMed ID: 3757730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased sodium-lithium countertransport in black non-insulin-dependent diabetic hypertensives.
    Johnson BA; Sowers JR; Zemel PC; Luft FC; Zemel MB
    Am J Hypertens; 1990 Jul; 3(7):563-5. PubMed ID: 2163648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic characteristics of the erythrocyte sodium-lithium countertransporter in subjects with coronary artery disease.
    Hardman TC; Barlow R; Dubrey SW; Croft P; Lant AF
    Am J Hypertens; 1996 Feb; 9(2):184-7. PubMed ID: 8924269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium-lithium countertransport has low affinity for sodium in hyperinsulinemic hypertensive subjects.
    Zerbini G; Ceolotto G; Gaboury C; Mos L; Pessina AC; Canessa M; Semplicini A
    Hypertension; 1995 May; 25(5):986-93. PubMed ID: 7737738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme (ACE) gene polymorphism and the erythrocyte sodium-lithium countertransporter (SLC) phenotype in hypertension.
    Hardman TC; Wierzbicki AS; Croft P; Feher M; Cox A; Lant AF
    J Hum Hypertens; 1996 Jun; 10(6):429-30. PubMed ID: 8872813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for an altered mode of action of the sodium-lithium countertransporter in vivo in patients with untreated essential hypertension.
    Brearley CJ; Wood AJ; Aronson JK; Grahame-Smith DG
    J Hypertens; 1993 Feb; 11(2):147-53. PubMed ID: 8385174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium-lithium countertransport in ambulatory hypertensive and normotensive patients.
    Turner ST; Boerwinkle E; Johnson M; Richelson E; Sing CF
    Hypertension; 1987 Jan; 9(1):24-34. PubMed ID: 2432010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Na+-Li+ countertransport in essential hypertension.
    De la Sierra A; Coca A; Aguilera MT; Urbano-Marquez A
    J Hypertens; 1988 Nov; 6(11):931-7. PubMed ID: 3235839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lipids affect maximum velocity not sodium affinity of human sodium-lithium countertransport: distinction from essential hypertension.
    Rutherford PA; Thomas TH; Laker MF; Wilkinson R
    Eur J Clin Invest; 1992 Nov; 22(11):719-24. PubMed ID: 1478240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The apolipoprotein E2 allele modulates activity and maximal velocity of the sodium-lithium countertransporter.
    Wierzbicki AS; Hardman TC; Cheung J; Lambert-Hammill M; Patel S; Morrish Z; Lumb PJ; Lant AF
    Am J Hypertens; 2002 Jul; 15(7 Pt 1):633-7. PubMed ID: 12118912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher urinary albumin excretion is associated with abnormal erythrocyte Na(+)/Li(+) countertransport (SLC) in non-modulating essential hypertensives and offspring of hypertensive parents.
    Sánchez RA; Giannone C; Masnatta LD; Baglivo HP; Ramírez AJ
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S128-32. PubMed ID: 11986910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte sodium-lithium countertransport in Chinese: its relationship to family history of hypertension.
    Lau YT; Wu D; Liang HC; Chen MC
    Clin Exp Hypertens A; 1992; 14(3):489-503. PubMed ID: 1318176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Na-Li countertransport kinetics in the relatives of hypertensive patients with abnormal Na-Li countertransport activity.
    Rutherford PA; Thomas TH; Wilkinson R
    Biochem Mol Med; 1997 Oct; 62(1):106-12. PubMed ID: 9367806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of sodium-lithium countertransport in normotensive and hypertensive subjects.
    Siebers RW; Maling TJ
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S59-61. PubMed ID: 1708027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulphydryl group control of sodium-lithium countertransport kinetics: a membrane protein control abnormality in essential hypertension.
    Thomas TH; Rutherford PA; West IC; Wilkinson R
    Eur J Clin Invest; 1995 Apr; 25(4):235-40. PubMed ID: 7601199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of erythrocyte Na+-K+ pump and cotransport in essential hypertension.
    Tuck ML; Corry DB; Maxwell M; Stern N
    Hypertension; 1987 Aug; 10(2):204-11. PubMed ID: 2440805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.